The BAP is a learned society and registered charity. It promotes research and education in psychopharmacology and related areas, and brings together people in academia, health services, and industry. Formed in 1974, it is the largest such national association in Europe, and the second largest in the world.

Read more about BAP

BAP 2018 Programme at a glance

Download the summary programme for this year's Summer Meeting in London
Read More

BAP 2018 in vivo Training Initiative

Applications for the 2018 round of the in vivo training initiative is now open
Read More

Certificate in Non-Clinical Psychopharmacology

Registration is open for the Non-Clinical Certificate in Cambridge 4th - 8th March 2018
Read More

Summer Meeting 2018

Join us in London 22nd to 25th July 2018
Read More

Fundamentals Wins BMA Award

Fundamentals of Clinical Psychopharmacology wins BMA Medical Book Award in Psychiatry
Read More

Fundamentals of Clinical Psychopharmacology

Buy a discounted copy of the new Fundamentals of Clinical Psychopharmacology
Read More

Online CPD Resource

RCPsych Online CPD Subscribers get a discount on the BAP Online Resource
Read More

The Ten Secrets of Success in Science

View Professor Trevor Robbins presenting his top tips
Read More

Neuroscience-based Nomenclature (NbN) for JoP

Journal of Psychopharmacology chosen to trial new NbN
Read More

Benefits of BAP membership include:

  • FREE subscription and access to the Journal of Psychopharmacology (published monthly online).
  • Reduced registration fees for the annual Summer Meeting.
  • Half price subscription to the Online CPD Resource.
  • Eligibility for prizes and awards.
  • Student bursaries for the BAP Summer Meeting and international conferences.
  • Reduced registration fees for selected partner association events.
  • 50% OFF Royal Society of Biology membership (Read more)
  • BAP Newsletter.
  • Voting for BAP Officers and Council (full members only).
  • Being part of one of the largest national psychopharmacology associations in the world.


How functional neuroimaging is informing cognitive neurobiological models of auditory verbal hallucinations
By Thomas Dunne
Posted on 11th October 2017

Introduction Auditory verbal hallucinations (AVHs), or “hearing voices”, are a complex phenomenon characterised by abnormal perceptions of speech occurring in the absence of an appropriate external stimulus.1 Hallucinations of this modality hold great diagnostic significance, with Schneider’s (1959) first-rank symptoms of schizophrenia (including AVHs) still recognised today by major classification systems such as the International […]

Not just a four-letter word: The role of neuroendocrine factors in romantic love
By Thomas Dunne
Posted on 25th September 2017

The dopamine reward pathwayIntroduction In his poem ‘Love’s Trinity’, Victorian poet laureate Alfred Austin presents a holistic view of love, describing its impact on both our psyche and physiology:1,2 ‘Soul, heart, and body, we thus singly name, Are not in love divisible and distinct, But each with each inseparably link’d’ (A Austin).3 Romantic love has influenced literature and […]

SYMPOSIUM 2: The psychopharmacology of emerging calcium channel targets
By Nerissa Culi
Posted on 29th July 2017

Calcium ions (Ca2+) are universal intracellular messengers and, through selectively permeable calcium channels, can mediate and drive many important...

See more articles


Barbara Sahakian
BBC Radio 5 Live: Microdosing with LSD
Barbara is interviewed by Chris Warburton about microdosing with LSD (from 1.38)
4th January 2018

Barbara Sahakian
Naked Scientist: Smart Drugs: What's the deal?
Barbara was interviewed by Naked Scientist about 'smart drugs'
7th November 2017

Sarah Bailey
New drug shows potential as a different kind of antidepressant in mouse trials
Sarah Bailey and her team have developed a potential new antidepressant and antianxiety treatment with a unique mechanism of action
6th November 2017

Stephen Lawrie
Life of a Scientist - Doing Bright Club!
Stephen performs at Bright Club at The Stand Comedy Club in Edinburgh in this vlog (08:25 - 10:26)
31st October 2017

Michael Browning and Erdem Pulcu
Wired: This computer model is unlocking why people suffer from depression
Michael Browning and BAP Summer Meeting poster prize winner Erdem Pulcu were interviewed by wired UK about their study that was presented at the Summer Meeting
19th October 2017

See more media


Human Brain Project SP8 Open Calls now published
8th February 2018

Calls for Expression of Interest for SGA2 are no open
Read More
BAP launches the President's biennial symposium
4th January 2018

BAP invites you to rethink street drugs and explore their use in the medical setting.
Read More
Professor Carmine Pariante awarded Distinguished Investigator Grant
15th December 2017

BAP Council Member Prof Carmine Pariante (IoPPN), awarded a Distinguished Investigator Grant by the Brain & Behavior Research Foundation
Read More
Unlicensed applications of licensed drugs in psychiatric practice: RCPsych and BAP work together to produce new guidance
7th December 2017

Unlicensed applications of licensed drugs in psychiatric practice: RCPsych and BAP work together to produce new guidance
Read More

See more news


Psychopharmacology is the study of drugs that affect mood, behaviour and cognition. It aims to develop our understanding of the actions and effects of such drugs, which may include treatments for psychiatric disorders as well as substances that can be abused.